TP53 and polycystic ovary syndrome: These results, consistent with bioinformatics analysis and qRT-PCR data, clearly indicate that protein levels of MDM2 significantly decreased in GCs of PCOS women in comparison to the controls, which consequently affects p53 levels and p53-mediated apoptosis pathway.